开发基于siRNA的抗细菌和病毒感染治疗方法的原则,应用和挑战:全面的综述
Hamid Motamedi1,2, Marzie Mahdizade Ari3,4, Amirhoushang Alvandi1,5
1Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Frontiers in microbiology
|June 28, 2024
概括
小干扰RNA (siRNA) 药物显示出治疗疾病的前景,其中一些已经获得批准. 本综述涵盖了进展,感染中的应用,传递挑战和siRNA治疗方法的未来方向.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基因沉默机制,特别是小干扰RNA (siRNA),已经推进了疾病治疗.
- 尽管取得了进展,治疗应用却面临着障碍.
- 第一个siRNA药物ONPATTRO于2018年被批准用于HTTR多神经病变.
研究的目的:
- 审查siRNA药物开发中的关键进展.
- 讨论siRNA在传染病中的影响.
- 探索siRNA治疗的输送系统,施用方法,局限性和未来前景.
主要方法:
- 关于基于siRNA的药物的临床前和临床研究的文献综述.
- 监管机构 (FDA,EMA) 批准的siRNA药物的分析.
- 讨论siRNA药物开发和应用中的挑战和潜在解决方案.
主要成果:
- 另外四种siRNA药物 (Givosiran,Inclisiran,Lumasiran,Vutrisiran) 已经获得批准.
- siRNA技术在治疗细菌和病毒感染方面显示出潜力.
- 传递系统和施用方法对于有效的siRNA疗法至关重要.
结论:
- 基于siRNA的药物代表了重要的治疗进步.
- 克服交付挑战对于更广泛的siRNA应用至关重要.
- 未来的发展有望扩大siRNA技术的治疗领域.
相关概念视频
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Small interfering RNAs (siRNA)
3.5K
3.5K
Types of RNA
63.5K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.5K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


